KATIE JENKINS: Open Payments
NPI 1740053677 · AUSTIN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,437 in 87 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,010 · 2025 $1,437
Food & beverage: $1,437
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $445 |
| ViiV Healthcare Company | 17 | $338 |
| Gilead Sciences, Inc. | 10 | $168 |
| Alkermes, Inc. | 7 | $141 |
| EMD Serono, Inc. | 3 | $48 |
| GlaxoSmithKline, LLC. | 3 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Lundbeck LLC | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Indivior Inc. | 2 | $29 |
Products named: DOVATO, VRAYLAR, MAVYRET, ARISTADA, UBRELVY, REXULTI, CABENUVA, TRELEGY ELLIPTA.
Industry payments across IN — which companies pay providers there.
